Fluorescence-Guided Imaging of Brain Tumors: A Safety Study Using SBK2-ICG
NCT07438860
·
clinicaltrials.gov ↗
PHASE1
Phase
NOT_YET_RECRUITING
Status
12
Enrollment
OTHER
Sponsor class
Conditions
Malignant Brain Tumors
Glioma
Interventions
DRUG:
SBK2-ICG
PROCEDURE:
Craniotomy (Standard of Care)
Sponsor
Tiffany Hodges